ArticleBMC medicine2015

Serum survivin predicts responses to treatment in active rheumatoid arthritis: a post hoc analysis from the SWEFOT trial.

Adrian Levitsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.